Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Neurol. 2011 Sep;68(9):1180-4. doi: 10.1001/archneurol.2011.191.

Laboratory abnormalities in patients with myotonic dystrophy type 2.

Author information

1
Neuromuscular Division, Department of Neurology, University of Rochester Medical Center, Rochester, NY 14642, USA. Chad_Heatwole@URMC.Rochester.edu

Abstract

BACKGROUND:

Myotonic dystrophy type 2 (DM2) is a recently discovered adult muscular dystrophy. Similar to DM1, this disease causes progressive debilitating weakness, clinical myotonia, and early cataracts and is thought to cause widespread physiologic dysfunction of multiple organ systems.

OBJECTIVE:

To analyze and compile the laboratory abnormalities of patients with DM2.

DESIGN:

Baseline DM2 laboratory data were compiled representing 68 different types of laboratory tests and 1442 total studies.

SETTING:

University medical center.

PATIENTS:

Eighty-three adults with genetically confirmed or clinically probable DM2 were identified. Of these patients, 49 had documented baseline laboratory screening.

MAIN OUTCOME MEASURES:

The individual frequencies of abnormal laboratory values in the population with DM2 studied.

RESULTS:

Of the 1442 studies, results for 359 (24.9%) were outside of their standard reference ranges. Of the 68 types of laboratory tests studied, 43 had values from 15 or more different patients with DM2. The relative frequency of an abnormally elevated laboratory value was greater than 50% in several tests, including the levels of creatine kinase, total cholesterol, lactate dehydrogenase, and alanine aminotransferase. In addition, serum levels of IgG were low in 75% of all patients with DM2 tested, and absolute lymphocyte counts were low in 54% of all patients with DM2 tested.

CONCLUSIONS:

There is a high frequency of laboratory abnormalities in patients with DM2. These abnormalities provide insight into the widespread pathologic manifestations of DM2 and may form a basis for clinical monitoring and disease screening.

PMID:
21911698
PMCID:
PMC3429333
DOI:
10.1001/archneurol.2011.191
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems Icon for PubMed Central
    Loading ...
    Support Center